XML 56 R44.htm IDEA: XBRL DOCUMENT v3.4.0.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 16, 2016
Mar. 24, 2012
Sep. 28, 2011
Mar. 24, 2010
May. 31, 2015
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Aug. 01, 2015
Jun. 30, 2015
May. 31, 2014
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets           $ 1,034,753   $ 676,803      
Subsidiary ownership percentage by parent                   91.00% 85.00%
Receivable from sale of intangible assets         $ 1,000,000            
Future payments to be received from sale of intangible assets         $ 1,000,000            
Equity ownership percentage after transaction                   20.00%  
Maximum amount of additional equity fundraising                   $ 10,000,000  
Ownership of investment           16.90%          
Carrying value of investment           $ 5,000,000         $ 0
Available-for-sale Securities                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)           395,758          
Available-for-sale Securities | VGX International [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)                 465,364    
GeneOne Life Sciences [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Payment received for license granted       $ 3,000,000              
Deferred revenue from affiliated entity       $ 3,000,000              
Period over which deferred revenue from affiliated entity will be recognized in years       8 years              
Revenue from related parties           $ 113,000 $ 113,000        
Operating expenses related to affiliated entity           212,000 $ 105,000        
Accounts receivable balance           7,000   4,000      
Accounts payable and accrued liability           207,000   165,000      
Long-term other assets           396,000   373,000      
OncoSec [Member] | First warrant [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (in shares)     50,000                
Term of the warrants in years     5 years                
Exercise price of a five-year warrant ($ per share)     $ 24.00                
OncoSec [Member] | Second warrant [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Common stock purchase warrant (in shares)   150,000                  
Term of the warrants in years   5 years                  
Exercise price of a five-year warrant ($ per share)   $ 20.00                  
VGX International [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets           $ 42,000   $ 29,000      
Director [Member]                      
Related-Party Transactions (Textual) [Abstract]                      
Term 5 years                    
Expenses to reimburse $ 3,100,000